Dopamine receptor (non-ergoline agonist)

Assets acting on this target.

Class
Non-ergoline dopamine agonist

By indication

Related mechanisms

Dopamine receptor (non-ergoline agonist) drugs compared

3 drugs, stage by indication
3 drugs acting on Dopamine receptor (non-ergoline agonist): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Apomorphine (Apokyn)ApokynBritannia Pharmaceuticals Ltd., Supernus Pharmaceuticalssmall moleculeApprovedApproved in Parkinson's Disease
Apomorphine (Onapgo)OnapgoBritannia Pharmaceuticals Ltd., Supernus Pharmaceuticalssmall moleculeApprovedApproved in Parkinson's Disease
SER-252 (PEOZ-apomorphine)Serina Therapeuticssmall moleculePhase 1Phase 1 in Parkinson's Disease

← all mechanisms